What did @thebossticks actually say?
The video features actor Josh Duhamel describing his personal peptide protocol to the creator. He says he uses NAD (both IV and injectable), plus "epimoralin and tesimoralin compound, which is like a synthetic HGH" that "promotes your own production of human growth hormone." He then walks through what he calls the Wolverine stack: BPC-157, TB-500, KPV, and GHK-Cu, all combined into a single daily injection. His stated reason is joint health and recovery, framed around being 50 and staying active. He does not claim to treat or cure any disease. He describes this as his personal routine, not a prescription recommendation, which is worth noting up front.
Does the science back this up?
Partially, and with significant caveats. The peptides he named are real, studied compounds, but the human trial data is thin across the board. Most of the evidence base is preclinical, meaning rodent studies or in-vitro work, not randomized controlled trials in humans.
BPC-157 has the most animal data of the group. Studies in rats, including Sikiric et al. (2018, Current Pharmaceutical Design), show accelerated tendon and ligament healing. There is no published Phase II or Phase III human clinical trial data for it. TB-500 (Thymosin Beta-4) has shown promise in cardiac repair and wound healing in animal models (Goldstein et al., 2012, Annals of the New York Academy of Sciences), but again, human data is sparse. GHK-Cu has reasonable evidence for skin repair and anti-inflammatory signaling (Pickart et al., 2015, Journal of Aging Research). KPV, a tripeptide fragment of alpha-MSH, has early research suggesting anti-inflammatory effects in gut models (Dalmasso et al., 2008, Peptides), but human safety data for injectable KPV specifically is essentially nonexistent.
What did they get wrong (or right)?
The terminology is worth scrutinizing. Duhamel calls his GHRH/GHRP combination "epimoralin and tesimoralin." These are almost certainly ipamorelin and tesamorelin, or possibly CJC-1295 with ipamorelin, mispronounced or misremembered. He is right that this class of compounds stimulates endogenous GH release rather than replacing it directly, and that distinction matters clinically. That part is accurate.
Where the framing gets murky is describing the combination as "like a synthetic HGH." It is not. Growth hormone secretagogues work on a completely different mechanism than exogenous HGH administration. Calling it "like synthetic HGH" blurs that line for a general audience and could create false equivalency with a controlled substance.
The claim that the entire Wolverine stack is taken in "one shot every day" is worth pausing on. Combining four peptides in a single compounded vial raises real stability and compatibility questions that are not addressed. That is not a small detail to skip over in a video with nearly 400,000 views.
What should you actually know?
None of the peptides discussed in this video are FDA-approved for the uses described. BPC-157 and TB-500 are not approved for human use at all in the United States. The FDA placed BPC-157 on its list of bulk drug substances that cannot be compounded in 2022. That is a regulatory fact, not a judgment on the underlying science.
GHK-Cu and KPV exist in a grayer area depending on delivery route and formulation. Tesamorelin (Egrifta) is FDA-approved, but only for HIV-related lipodystrophy, not general wellness or anti-aging. Using it off-label in a compounded form is a different regulatory category entirely.
Celebrity wellness content moves fast, and the gap between "this compound has interesting preclinical data" and "this is a proven protocol for joint recovery" is enormous. The animal models are intriguing. The human evidence is not there yet. Anyone considering a protocol like this should be working with a licensed provider who can review their individual history, not a TikTok clip.
Bottom line
Duhamel is not making wild pseudoscience claims here. The compounds are real, the joint recovery rationale is biologically plausible, and he describes his own routine rather than telling viewers to copy it. But the video glosses over significant regulatory and safety gaps, particularly around BPC-157's compounding ban and the practical questions of mixing four peptides into one daily shot. Interesting content. Incomplete picture.